Anticoagulant and antithrombotic action of the Factor Xa inhibitor antistasin (ATS)
- 15 July 1993
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 71 (2) , 169-174
- https://doi.org/10.1016/0049-3848(93)90183-o
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Selective factor Xa inhibition by recombinant antistasin prevents vascular graft thrombosis in baboons.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.Circulation, 1992
- Anticoagulant effects of the selective factor Xa inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibitionThrombosis Research, 1991
- Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis.Circulation, 1991
- Purification and characterization of recombinant antistasin: A leech-derived inhibitor of coagulation factor XaArchives of Biochemistry and Biophysics, 1991
- Biologic assay of a thrombosis-inducing activity in human serumJournal of Applied Physiology, 1959